SAM
INSM icon

Smartleaf Asset Management’s Insmed INSM Stock Holding History

Smartleaf Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Buy
1,747
+304
+21% +$46.7K 0.01% 694
2025
Q4 		$251K Buy
1,443
+657
+84% +$120K 0.01% 708
2025
Q3 		$111K Buy
786
+405
+106% +$49.6K 0.01% 1008
2025
Q2 		$37.9K Sell
381
-388
-50% -$29.7K ﹤0.01% 1276
2025
Q1 		$60K Sell
769
-61
-7% -$4.67K 0.01% 1058
2024
Q4 		$57.2K Buy
830
+411
+98% +$29.6K 0.01% 1116
2024
Q3 		$30.4K Buy
419
+78
+23% +$5.76K ﹤0.01% 1112
2024
Q2 		$22.8K Buy
+341
New +$13.2K ﹤0.01% 984

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smartleaf Asset Management's INSM Position: Q1 2026 in Review

Smartleaf Asset Management increased its Insmed (INSM) stake by 21% in Q1 2026, buying an estimated $46.7K and bringing the position to 1,747 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #694.

Smartleaf Asset Management first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Smartleaf Asset Management held 1,747 shares of Insmed worth $268K as of Q1 2026.
  • Smartleaf Asset Management bought 304 Insmed shares in Q1 2026, an estimated $46.7K.
  • Insmed made up 0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #694 holding.
  • Smartleaf Asset Management first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.